Quest Diagnostics
DGX
#863
Rank
โ‚น2.649 T
Marketcap
โ‚น24,002
Share price
0.35%
Change (1 day)
46.93%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

EPS for Quest Diagnostics (DGX)

EPS in 2023 (TTM): โ‚น557.74

According to Quest Diagnostics 's latest financial reports the company's current EPS (TTM) is โ‚น955.85. In 2022 the company made an earnings per share (EPS) of โ‚น756.79 a decrease over its 2021 EPS that were of โ‚น1,490.

EPS history for Quest Diagnostics from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น557.74-26.3%
2022โ‚น756.79-49.21%
2021โ‚น1,49049.72%
2020โ‚น995.2966.67%
2019โ‚น597.1718%
2018โ‚น506.09-4.26%
2017โ‚น528.6323.19%
2016โ‚น429.10-7.11%
2015โ‚น461.9628.46%
2014โ‚น359.62-31.61%
2013โ‚น525.8160.46%
2012โ‚น327.69-16.51%
2011โ‚น392.482.45%
2010โ‚น383.094.35%
2009โ‚น367.1330.77%
2008โ‚น280.7568.93%
2007โ‚น166.19-40.6%
2006โ‚น279.819.96%
2005โ‚น254.4610.39%
2004โ‚น230.5116.35%
2003โ‚น198.1226.73%
2002โ‚น156.3490.29%
2001โ‚น82.1653.51%
2000โ‚น53.52-22900%
1999-โ‚น0.23-101.11%
1998โ‚น21.13-216.88%
1997-โ‚น18.07

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
LabCorp
LH
โ‚น1,152 20.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
-โ‚น66.83-106.99%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚น23.47-102.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
โ‚น186.37-80.50%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
-โ‚น19.72-102.06%๐Ÿ‡บ๐Ÿ‡ธ USA